Meta-analysis of ATRIA versus CHA₂DS₂-VASc for predicting stroke and thromboembolism in patients with atrial fibrillation

详细信息    查看全文

• 作者：Wengen Zhu ; M.D.^a ; ¹ ; Linghua Fu ; M.S.^a ; ¹ ; Ying Ding ; M.D.^a ; ¹ ; Lin Huang ; M.D.^a ; Zhenyan Xu ; M.D.^a ; Jinzhu Hu ; M.D.^a ; Kui Hong ; M.D. ; Ph.D.^a ; ^b ; ^{hongkui88@163.com}
• 关键词：Atrial fibrillation ; ATRIA ; CHA2DS2-VASc ; Stroke ; Thromboembolism
• 刊名：International Journal of Cardiology
• 出版年：2017
• 出版时间：15 January 2017
• 年：2017
• 卷：227
• 期：Complete
• 页码：436-442
• 全文大小：610 K
• 卷排序：227

文摘

ATRIA performed better than CHA2DS2-VASc for stroke risk prediction. CHA2DS2-VASc was superior to ATRIA for identifying truly “low risk” patients.